Myriad Genetics, Inc. (MYGN)
4.28
-0.34
(-7.36%)
USD |
NASDAQ |
Mar 27, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Total Liabilities (Quarterly) : 338.60M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 33.94B |
| Insulet Corp. | 1.675B |
| Pacific Biosciences of California, Inc. | 778.73M |
| Tandem Diabetes Care, Inc. | 725.94M |
| iRhythm Holdings, Inc. | 867.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 706.60M |
| Shareholders Equity (Quarterly) | 368.00M |
| Debt to Equity Ratio | 0.5701 |
| Current Ratio | 2.486 |
| Net Debt Paydown Yield | -2.32% |